Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Page values for "Quetiapine"

From Pharmacopedia
More actions

"Medicines" values

1 row is stored for this page
FieldField typeValue
genericStringQuetiapine
brandStringSeroquel
structureFile
classesList of String, delimiter: ,[[:Category:Neuroleptics|Neuroleptic]] [[:Category:Second-generation neuroleptics|Second-generation (atypical) neuroleptic]] [[:Category:Dibenzothiazepines|Dibenzothiazepine]] [[:Category:Serotonin-dopamine antagonists|Serotonin-dopamine antagonist]]
mechanismStringDopamine D2 and serotonin 5-HT2A receptor antagonist'"`UNIQ--ref-0000008D-QINU`"' '"`UNIQ--vote-0000008E-QINU`"'
usesString'"`UNIQ--vote-0000008F-QINU`"', '"`UNIQ--vote-00000090-QINU`"', '"`UNIQ--vote-00000091-QINU`"', '"`UNIQ--vote-00000092-QINU`"'
starting_doseString25 mg (schizophrenia, immediate-release); 50 mg (bipolar mania, immediate-release); 50 mg (Seroquel XR, schizophrenia or bipolar)
preparationsString25 mg, 50 mg, 100 mg, 200 mg, 300 mg, 400 mg immediate-release tablets; 50 mg, 150 mg, 200 mg, 300 mg, 400 mg extended-release tablets (Seroquel XR)
fda_maxString800 mg/day
pill_idText* '''25 mg:''' peach round film-coated tablet * '''50 mg:''' white round film-coated tablet * '''100 mg:''' yellow round film-coated tablet * '''200 mg:''' white round film-coated tablet * '''300 mg:''' white capsule-shaped film-coated tablet * '''400 mg:''' yellow capsule-shaped film-coated tablet * '''XR tablets:''' film-coated, varying shapes and colors by strength
routesList of String, delimiter: ,Oral
onsetString30-60 min (sedation); days to weeks (neuroleptic effect)
durationString6-8 h (immediate-release); 24 h (extended-release)
halflifeString~6 h (parent compound, immediate-release); ~9-12 h (active metabolite N-desalkylquetiapine, also called norquetiapine)
bioavailabilityStringTablet ~100% relative to oral solution; extensive first-pass metabolism
pregnancyStringPregnancy categories were retired by FDA in 2015. Quetiapine has reassuring active-comparator cohort data without consistent teratogenic signal; among the preferred neuroleptics when treatment is clinically necessary in pregnancy. See pregnancy_details for the full citation set.
legalString[[USLegal:Prescription only|Prescription only]]; not a controlled substance